Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LYMPHOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT05611086
What this trial is testing

N-Acetylcysteine vs Placebo as Adjunctive Treatment in Pediatric Leukemia

Who this might be right for
Lymphoblastic Leukemia, Acute, Childhood
Teny Tjitra Sari 16
Testing effectiveness (Phase 2)UnknownNCT03655483
What this trial is testing

Study of GLS-010 Injection in the Treatment of Classical Hodgkin's Lymphoma

Who this might be right for
Classical Hodgkin's Lymphoma
Guangzhou Gloria Biosciences Co., Ltd. 85
Not applicableStudy completedNCT01988272
What this trial is testing

Imaging Based Dosimetry for Individualized Internal Emitter Therapy

Who this might be right for
Non-Hodgkin's Lymphoma
University of Michigan 33
Testing effectiveness (Phase 2)UnknownNCT05054465
What this trial is testing

A Phase 1b-2 Trial to Assess Venetoclax and Navitoclax Consolidation and Post-transplant Maintenance in High-risk Patients With T-ALL

Who this might be right for
Acute Lymphoblastic Leukemia
Israeli Medical Association 48
Testing effectiveness (Phase 2)Ended earlyNCT03547700
What this trial is testing

Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Lymphoma, T-Cell, Peripheral
University of Michigan Rogel Cancer Center 11
Early research (Phase 1)Active Not RecruitingNCT03220022
What this trial is testing

Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas

Who this might be right for
AIDS-Related LymphomaAnn Arbor Stage II Diffuse Large B-Cell LymphomaAnn Arbor Stage III Diffuse Large B-Cell Lymphoma+1 more
National Cancer Institute (NCI) 46
Not applicableUnknownNCT04931875
What this trial is testing

Total-body PET / CT in the Evaluation of Treatment and Prognosis of Lymphoma

Who this might be right for
Lymphoma
RenJi Hospital 100
Testing effectiveness (Phase 2)UnknownNCT03156101
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in R/R ALL and Lymphoma Subjects

Who this might be right for
Relapsed B-cell Acute Lymphoblastic LeukemiaRefractory B-cell Acute Lymphoblastic LeukemiaRelapsed／Refractory B-cell Lymphoma
Shenzhen BinDeBio Ltd. 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05926765
What this trial is testing

AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

Who this might be right for
Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands
MeiraGTx, LLC 290
Not applicableLooking for participantsNCT05377307
What this trial is testing

Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy

Who this might be right for
Diffuse Large B Cell LymphomaLarge B-cell LymphomaPrimary Mediastinal Large B Cell Lymphoma+2 more
Pell Bio-Med Technology Co., Ltd. 49
Not applicableEnded earlyNCT00710151
What this trial is testing

Neurotoxicity in Primary Central Nervous System Lymphoma (PCNSL): An International Observational Study of Cognition in Long Term Survivors

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)
OHSU Knight Cancer Institute 80
Not applicableStudy completedNCT00511537
What this trial is testing

Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders

Who this might be right for
CMLALLAML+3 more
University of California, San Francisco 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04278781
What this trial is testing

AG-120 in People With IDH1 Mutant Chondrosarcoma

Who this might be right for
ChondrosarcomaChondrosarcoma, Grade 2Chondrosarcoma, Grade 3+1 more
Memorial Sloan Kettering Cancer Center 6
Not applicableEnded earlyNCT00176930
What this trial is testing

Stem Cell Transplant for Hematological Malignancy

Who this might be right for
Leukemia, Myeloid, ChronicAMLLeukemia, Lymphocytic, Acute+6 more
Masonic Cancer Center, University of Minnesota 330
Not applicableUnknownNCT04776265
What this trial is testing

RWE of Brentuximab Vedotin Consolidation in Patients With RR HL Who Receive Salvage Chemotherapy and ASCT

Who this might be right for
Hodgkin Lymphoma, AdultRelapsed Hodgkin's Disease, AdultRefractory Hodgkin Lymphoma
Grupo Argentino de Tratamiento de la Leucemia Aguda 100
Early research (Phase 1)Study completedNCT00012207
What this trial is testing

Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Fred Hutchinson Cancer Center 12
Testing effectiveness (Phase 2)UnknownNCT05801107
What this trial is testing

Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients

Who this might be right for
Non-small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 30
Early research (Phase 1)UnknownNCT06279611
What this trial is testing

An Evaluation of LY007 Cell Injection for r/r B-NHL

Who this might be right for
B-NHL
Shanghai Longyao Biotechnology Inc., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT00284271
What this trial is testing

Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma

Who this might be right for
Hodgkin´s Lymphoma
University of Cologne 65
Early research (Phase 1)Study completedNCT01221571
What this trial is testing

Assess AFM13 in Patients With Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Affimed GmbH 28
Next Page